Featured Research

from universities, journals, and other organizations

New Technology Offers Alternative To Open Heart Surgery

Date:
November 20, 2006
Source:
Blackwell Publishing Ltd.
Summary:
A new method of treating mitral regurgitation (MR), the leaking of blood through the mitral valve into the heart chamber, provides a less-invasive alternative to open heart surgery. A study published in Journal of Interventional Cardiology found that a variety of advances have allowed for the potential treatment of MR through various catheter techniques, similar to angioplasty. While over 50,000 mitral valve surgical procedures are performed annually, open surgery is an undesirable option, especially for high-risk patients.

A new method of treating mitral regurgitation (MR), the leaking of blood through the mitral valve into the heart chamber, provides a less-invasive alternative to open heart surgery.

A study published in Journal of Interventional Cardiology found that a variety of advances have allowed for the potential treatment of MR through various catheter techniques, similar to angioplasty. While over 50,000 mitral valve surgical procedures are performed annually, open surgery is an undesirable option, especially for high-risk patients.

The study reports on the first phase of a clinical trial that employed this new treatment method on surgical candidates with moderate-severe and severe MR. The procedure involved the positioning of a guide catheter in the left atrium of the heart, far less invasive than open heart surgery.

“The procedure has been accomplished safely and a significant reduction in MR has been achieved in the majority of patients treated,” according to Dr. Ted Feldman, lead researcher of the study.

In the United States , as many as 250,000 patients with valvular heart disease suffer from MR and an additional 2 million Americans with other heart diseases experience it to some degree. The study marks a groundbreaking step in the development of new therapies as well as an advance in knowledge of heart surgery.


Story Source:

The above story is based on materials provided by Blackwell Publishing Ltd.. Note: Materials may be edited for content and length.


Cite This Page:

Blackwell Publishing Ltd.. "New Technology Offers Alternative To Open Heart Surgery." ScienceDaily. ScienceDaily, 20 November 2006. <www.sciencedaily.com/releases/2006/11/061120055153.htm>.
Blackwell Publishing Ltd.. (2006, November 20). New Technology Offers Alternative To Open Heart Surgery. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2006/11/061120055153.htm
Blackwell Publishing Ltd.. "New Technology Offers Alternative To Open Heart Surgery." ScienceDaily. www.sciencedaily.com/releases/2006/11/061120055153.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins